Melrose, MA, United States of America

Christopher R Deuel

This inventor holds 35 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Endoscopic Suturing. Top assignee: Boston Scientific Scimed, Inc.. Active years: 2021-2026.

USPTO Granted Patents = 35 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Endoscopic Suturing
Suture Cinching
Tissue Engagement
Grasping Devices
Closure Devices
Control Mechanisms
Suture Attachment
Articulation Locking
Endoscope Mechanisms
Tissue Fastening
Suture Needle Devices
Medical Devices
35 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christopher R Deuel

Introduction: Christopher R Deuel, a talented inventor hailing from Melrose, MA (US), has made significant contributions to the world of innovations with his creative mind and dedication.

Latest Patents: Christopher R Deuel holds several patents in various fields, showcasing his versatility and expertise in inventing groundbreaking solutions to complex problems.

Career Highlights: Throughout his illustrious career, Christopher R Deuel has demonstrated a keen ability to transform ideas into tangible inventions that have the potential to revolutionize industries and improve people's lives.

Collaborations: Christopher R Deuel has collaborated with leading research institutions, universities, and companies to further his innovative projects, demonstrating his commitment to pushing the boundaries of what is possible.

Conclusion: Christopher R Deuel's passion for innovation, coupled with his relentless drive to create, solidifies his position as a prominent figure in the world of inventors, leaving a lasting impact on the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…